Delivery Order SPE2DB22D1106-SPE2DB24FFDG1
Award Date
7/22/24
Potential Completion Date
7/23/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.45 firm fixed-price delivery order is for the supply of 150 unit/mL vials of the pharmaceutical product HYLENEX. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HYLENEX 150 UNITS/ML VIAL medical products. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a Ceiling Value of $1,027.30 with an Ultimate Completion Date of July 10, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DX15D1022|SPE2DX24FVLBT, is for the delivery order of HYLENEX 150 UNITS/ML VIALML. The $1,368.00 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a completion date of July 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,566,110,956 units of HYLENEX, a 150 units/mL injectable medication, at a ceiling value of $1,907.57. The delivery order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of...
The Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $4,756.92 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HYQVIA 5 GM-400 UNIT PACK 52.5ML, a pharmaceutical product, with a completion date of September 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $14,314.27, covers the delivery of ELCYS 500 MG/10 ML VIAL 10ML medical products. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a final completion date of February 7, 2025. The award is not associated with any set-aside designation, indicating open...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,790.80, is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialized pharmaceutical product. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price arrangement. This award is part of Amerisourcebergen's larger $999,999,999 IDC with the DLA, which...
This federal contract award, with a total ceiling value of $7,513.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply...
This federal contract award, valued at $1,039.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HyperHEP B Vial 5 mL, a pharmaceutical product, with a ceiling value of $2,539.86 and a period of performance through April 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that DLA awarded solely to Amerisourcebergen Drug Corp as the prime contractor. The...